A Study to Measure the Expression of the HER2-HER3 Dimer in Tumour and Blood (Exosomes) Samples From Patients With HER2 Positive Breast Cancer Receiving HER2 Targeted Therapies
Clinical trial NCT04288141 · UNKNOWN
Trial details
- NCT number
- NCT04288141
- Sponsor
- King's College London
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2019-12-20
- Primary completion
- 2023-06-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.